Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats.
Assessing insulin resistance in rodent models gives insight into mechanisms that cause type 2 diabetes and the metabolic syndrome. The hyperinsulinemic euglycemic glucose clamp, the reference standard for measuring insulin sensitivity in humans and animals, is labor intensive and technically demanding. A number of simple surrogate indexes of insulin sensitivity/resistance have been developed and validated primarily for use in large human studies. These same surrogates are also frequently used in rodent studies. However, in general, these indexes have not been rigorously evaluated in animals. In a recent validation study in mice, we demonstrated that surrogates have a weaker correlation with glucose clamp estimates of insulin sensitivity/resistance than in humans. This may be due to increased technical difficulties in mice and/or intrinsic differences between human and rodent physiology. To help distinguish among these possibilities, in the present study, using data from rats substantially larger than mice, we compared the clamp glucose infusion rate (GIR) with surrogate indexes, including QUICKI, HOMA, 1/HOMA, log (HOMA), and 1/fasting insulin. All surrogates were modestly correlated with GIR (r = 0.34-0.40). Calibration analyses of surrogates adjusted for body weight demonstrated similar predictive accuracy for GIR among all surrogates. We conclude that linear correlations of surrogate indexes with clamp estimates and predictive accuracy of surrogate indexes in rats are similar to those in mice (but not as substantial as in humans). This additional rat study (taken with the previous mouse study) suggests that application of surrogate insulin sensitivity indexes developed for humans may not be appropriate for determining primary outcomes in rodent studies due to intrinsic differences in metabolic physiology. However, use of surrogates may be appropriate in rodents, where feasibility of clamps is an obstacle and measurement of insulin sensitivity is a secondary outcome.
Muniyappa
Ranganath
R
Diabetes Unit, NCCAM, NIH, 9 Memorial Dr., Bldg. 9, Rm. 1N-105 MSC 0920, Bethesda, MD 20892-0920, USA. quonm@nih.gov
Chen
Hui
H
Muzumdar
Radhika H
RH
Einstein
Francine H
FH
Yan
Xu
X
Yue
Lilly Q
LQ
Barzilai
Nir
N
Quon
Michael J
MJ
D000818:Animals; D001835:Body Weight / Q000502:physiology; D002138:Calibration; D005215:Fasting / Q000378:metabolism; D005260:Female; D015309:Glucose Clamp Technique; D006706:Homeostasis / Q000502:physiology; D006946:Hyperinsulinism / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology*; D016014:Linear Models; D011237:Predictive Value of Tests; D051381:Rats; D017207:Rats, Sprague-Dawley
Diabetes. 2002 Oct;51(10):2951-8
12351432
Diabetes Care. 2003 Aug;26(8):2426-32
12882874
Endocr Rev. 2007 Feb;28(1):48-83
17018838
Circ Res. 2007 May 25;100(10):1415-27
17525381
J Clin Endocrinol Metab. 2004 Mar;89(3):1481-4
15001651
J Clin Endocrinol Metab. 2004 Jan;89(1):135-41
14715840
Physiol Rev. 2004 Apr;84(2):623-47
15044684
Diabetes Care. 1999 Sep;22(9):1462-70
10480510
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E451-5
18073320
Med Clin North Am. 2004 Jul;88(4):787-835, ix
15308380
Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15-26
17957034
Diabetes. 2007 May;56(5):1268-76
17303807
Nat Med. 2002 Jul;8(7):731-7
12068289
Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E985-91
10826999
Contemp Top Lab Anim Sci. 2004 Nov;43(6):42-51
15669134
Am J Physiol Endocrinol Metab. 2007 May;292(5):E1378-87
17227956
Diabetes. 2006 Oct;55(10):2788-96
17003344
J Clin Endocrinol Metab. 2001 Nov;86(11):5457-64
11701722
PLoS One. 2009 Jul 22;4(7):e6334
19623253
Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R111-7
10644628
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6086-91
15837923
Diabetes. 2006 Dec;55(12):3594-603
17130509
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E261-70
18003716
Best Pract Res Clin Endocrinol Metab. 2003 Sep;17(3):305-22
12962688
Diabetes. 2005 Jul;54(7):1914-25
15983190
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
10902785
Diabetologia. 1985 Jul;28(7):412-9
3899825
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1269-76
18796548
Recent Prog Horm Res. 2004;59:207-23
14749503
Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E804-12
12678026